Insiders · Profile

Aryeh Jason

Director at LIGAND PHARMACEUTICALS · Director at Orchestra BioMed. Filing since 30 May 2007. CIK 0001376960

Company
Date
Role
Action
Shares
Amount
Of holding
11 Jun 2026
Director
Sold at will
4,500
$1.13M
4.2%
10 Jun 2026
Director
Sold at will
500
$125.00K
0.5%
18 May 2026
Director
Bought
665
$2.49K
0.6%
15 May 2026
Director
Bought
8,971
$34.99K
8.3%
23 Sep 2025
Director
Sold at will
10,000
$1.71M
12.6%
19 Sep 2025
Director
Bought
1,000
$2.45K
0.9%
3 Sep 2019
Director
Bought
750
$65.26K
1.1%
5 Aug 2019
Director
Bought
746
$67.15K
1.1%
31 Jul 2019
Director
Bought
754
$70.12K
1.2%
30 Jul 2019
Director
Bought
3,000
$300.66K
4.8%
29 Jul 2019
Director
Bought
250
$26.50K
0.4%
11 Jun 2019
Director
Bought
250
$26.75K
0.4%
31 May 2019
Director
Bought
500
$54.26K
0.8%
30 May 2019
Director
Bought
250
$27.50K
0.4%
29 May 2019
Director
Bought
250
$27.75K
0.4%
20 May 2019
Director
Bought
250
$28.00K
0.4%
14 May 2019
Director
Bought
250
$28.13K
0.4%
13 Mar 2019
Director
Bought
202
$22.73K
0.4%
17 Aug 2018
Director
Sold, plan not stated
26,862
$6.50M
34.3%
16 Aug 2018
Director
Sold, plan not stated
1,080
$264.60K
1.4%
9 Mar 2018
Director
Sold, plan not stated
4,000
$705.90K
4.8%
8 Mar 2018
Director
Sold, plan not stated
3,500
$612.10K
4.0%
23 Feb 2018
Director
Sold, plan not stated
3,417
$529.64K
3.8%
17 Nov 2017
Director
Sold, plan not stated
24,400
$3.42M
21.3%
23 Aug 2017
Director
Sold, plan not stated
2,000
$255.98K
1.7%
12 May 2017
Director
Sold, plan not stated
14,582
$1.63M
11.1%
11 May 2017
Director
Sold, plan not stated
22,665
$2.49M
14.7%
28 Feb 2017
Director
Sold, plan not stated
7,000
$753.06K
4.4%
27 Feb 2017
Director
Sold, plan not stated
25,000
$2.65M
13.4%
25 Nov 2016
Director
Sold, plan not stated
3,478
$372.01K
1.8%
22 Nov 2016
Director
Sold, plan not stated
15,001
$1.61M
7.3%
18 Nov 2016
Director
Sold, plan not stated
5,000
$525.00K
2.4%
16 Nov 2016
Director
Sold, plan not stated
1,330
$141.42K
0.6%
6 May 2016
Director
Sold, plan not stated
15,000
$1.78M
6.6%
5 May 2016
Director
Sold, plan not stated
10,000
$1.20M
4.2%
8 Mar 2016
Director
Sold, plan not stated
500
$51.25K
0.2%
7 Mar 2016
Director
Sold, plan not stated
5,629
$568.89K
2.3%
11 Nov 2015
Director
Sold, plan not stated
3,000
$304.47K
1.2%
4 Jun 2015
Director
Sold, plan not stated
1,640
$152.00K
0.7%
20 May 2015
Director
Sold, plan not stated
1,000
$87.65K
0.4%
19 May 2015
Director
Sold, plan not stated
2,240
$198.96K
0.9%
18 May 2015
Director
Sold, plan not stated
6,000
$520.44K
2.3%
9 Oct 2014
Director
Bought
11,000
$472.89K
4.5%
14 Feb 2014
Director
Sold, plan not stated
9,500
$749.27K
3.7%
13 Feb 2014
Director
Sold, plan not stated
6,700
$518.78K
2.6%
12 Feb 2014
Director
Sold, plan not stated
24,120
$1.81M
8.5%
1 Jun 2012
Director
Bought
700
$8.39K
0.2%
10 Nov 2011
Director
Bought
1,000
$11.01K
0.4%
10 Nov 2011
Director
Bought
1,000
$10.90K
24.8%
10 Aug 2011
Director
Bought
2,000
$21.14K
0.7%
12 May 2011
Director
Bought
1,725
$18.91K
0.6%
16 Mar 2011
Director
Bought
4,000
$37.41K
1.5%
15 Mar 2011
Director
Bought
1,500
$14.24K
0.6%
14 Mar 2011
Director
Bought
3,500
$33.90K
1.3%
11 Mar 2011
Director
Bought
3,000
$29.53K
1.1%
11 Mar 2011
Director
Bought
1,000
$9.83K
49.4%
10 Mar 2011
Director
Bought
1,000
$10.05K
49.4%
10 Mar 2011
Director
Bought
500
$5.08K
0.2%
23 Feb 2011
Director
Bought
5,000
$49.70K
1.9%
1 Jun 2010
Director
Bought
5,000
$7.40K
6.1%
25 May 2010
Director
Bought
7,500
$10.75K
15.6%
24 May 2010
Director
Bought
2,803
$4.06K
6.2%
20 May 2010
Director
Bought
592
$874.27
1.3%
30 May 2007
Director
Bought
5,000
$32.40K
20.2%
30 May 2007
Director
Bought
3,350
$21.71K
38.1%
65 decisions on file.